n:m Phase-Locking of Heterogeneous and Strongly Coupled Oscillators
Mathematical breakthrough simplifies analysis of coupled biological oscillators with nonlinear heterogeneity.
Researchers have long struggled to model the complex phase-locking behavior of biological oscillators—from neurons firing in the brain to heart cells beating in unison—because real systems involve strong coupling and inherent heterogeneity between oscillators. Existing methods either assumed identical oscillators or were limited to weak coupling, failing to capture the nonlinear dynamics that govern phenomena like 4:1 or 3:2 locking patterns. In a new paper, Youngmin Park presents a scalar reduction technique that handles both nonlinear coupling strength and nonlinear heterogeneity simultaneously, reducing high-dimensional oscillator networks to a single scalar equation.
The method's power lies in its ability to predict exactly when n:m phase-locked states emerge and disappear as parameters vary. Park validated the approach on three distinct biological models: the nonradial isochron clock (relevant to circadian rhythms), a thalamic neural oscillator (important for sleep-wake cycles), and the classic Van der Pol oscillator (used in cardiac modeling). The analysis, spanning 58 pages with 28 figures, reveals that even tiny amounts of heterogeneity—effects that would be ignored by standard identical-oscillator assumptions—can dramatically shift locking patterns. This work opens the door to studying more biologically realistic, high-dimensional networks without sacrificing analytical tractability.
- Scalar reduction method works for strong coupling and nonlinear heterogeneity, not just weak coupling or identical oscillators.
- Validated on three models: nonradial isochron clock, thalamic neural oscillator, and Van der Pol oscillator.
- Small heterogeneity significantly alters n:m phase-locked states, a finding missed by traditional identical-oscillator approaches.
Why It Matters
Enables realistic modeling of neural and cardiac synchrony, advancing treatment for epilepsy, arrhythmias, and circadian disorders.